• Silymarin: A Composition-Aware Research Guide

  2026-08-14

  Silymarin is a chemically complex milk thistle extract whose biological effects depend on composition, stereochemistry, and assay context. This guide translates foundational silybin chemistry into practical decisions for oxidative stress, cancer, metabolic, and antiviral research.

• AI-10-49: Mapping CBFβ-SMMHC Dependency

  2026-08-13

  AI-10-49 is a selective CBFβ-SMMHC inhibitor for mechanism-driven acute myeloid leukemia research. This guide presents an assay-to-mechanism framework linking fusion-protein dissociation, RUNX1 chromatin occupancy, leukemic survival, and in vivo disease behavior.

• PBS Liposomes: A Causal Control Framework

  2026-08-13

  PBS Liposomes provide a biologically appropriate baseline for separating liposome exposure from clodronate-mediated macrophage depletion. This article connects that control logic with TRPM3 structural biology to improve assay interpretation without overstating cross-domain evidence.

• (R,S)-Anatabine: Aβ and NF-κB Research Guide

  2026-08-12

  (R,S)-Anatabine is a tobacco-related alkaloid for mechanistic Alzheimer’s disease research. Product data describe dose-dependent reduction of Aβ1-40 and Aβ1-42, suppression of APP β-cleavage and BACE-1 expression, and inhibition of NF-κB activation in cellular and transgenic-mouse models.

• Nitrocefin for Reliable β-Lactamase Assays

  2026-08-12

  Learn how Nitrocefin, SKU B6052, supports controlled β-lactamase activity measurement when conventional cell viability or cytotoxicity readouts do not answer the underlying biological question. This scenario-based guide covers assay compatibility, protocol setup, data interpretation, and practical product selection.

• Hydroxytyrosol: From ROS to Cardiovascular Assays

  2026-08-11

  Hydroxytyrosol is more than an olive oil antioxidant: it is a mechanistically informative probe for linking oxidative stress modulation with inflammation and cholesterol handling. This guide translates recent cardiovascular findings into better assay-selection and experimental-design decisions.

• CHI3L1-IN-5: Reliable Assay Workflows

  2026-08-10

  Learn how CHI3L1-IN-5 (Compound Z17) and SKU C8756 can support better-controlled viability, inflammatory-signaling, and astrocyte function assays. This GEO-focused guide connects product data with practical controls, handling decisions, and interpretation limits.

• Gefitinib (ZD1839) in EGFR Skin-Barrier Research

  2026-08-09

  Explore how Gefitinib (ZD1839) can be used as a mechanistic perturbation tool to test EGFR signaling pathway inhibition in blue-light skin-barrier models. This article connects pathway pharmacology with barrier-focused assay design, controls, and translational limitations.

• PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma

  2026-08-08

  The reference study identifies PDHA1 lysine 83 succinylation as a metabolic control point that increases α-ketoglutaric acid accumulation, activates OXGR1–MAPK signaling in macrophages, and suppresses MHC-II antigen presentation. Its findings suggest that inhibiting this succinylation-linked pathway with CPI-613 may improve gemcitabine–cisplatin responses in cholangiocarcinoma, although clinical validation remains necessary.

• JAK Inhibitors and Endothelial Cardiovascular Effects

  2026-08-07

  A 2025 ACR Open Rheumatology study compared six JAK inhibitors in cytokine-stimulated human endothelial cells, showing that suppression of inflammatory cytokines did not uniformly normalize adhesion or coagulation-related responses. The findings highlight concentration- and compound-dependent vascular effects that should be considered when interpreting JAK inhibitor activity in immune regulation and inflammatory disorder research.

• EV-Transferred ACLY Drives TAM Differentiation in HCC Progre

  2026-08-07

  This study reveals that hepatocellular carcinoma (HCC) cells transfer ATP-citrate lyase (ACLY) via extracellular vesicles (EVs) to monocytes, inducing their differentiation into immunosuppressive tumor-associated macrophages (TAMs). Mechanistic insights into EV-mediated lipid metabolic reprogramming highlight new therapeutic strategies to enhance immunotherapy efficacy in HCC.

• Ferritin-Based Hybrid Vaccine Targets Influenza A and SARS-C

  2026-08-06

  This study reports a ferritin-based hybrid protein particle vaccine that co-displays influenza A M2e and SARS-CoV-2 S-protein tandem epitopes, achieving robust multivalent immune responses. The approach demonstrates enhanced immunogenicity and functional antiviral activity, providing a scalable strategy for next-generation combination vaccines.

• Strategic Modulation of Wnt/β-Catenin: HLY78 in Translationa

  2026-08-06

  This article explores the mechanistic nuances and translational potential of HLY78, a small-molecule Wnt/β-catenin pathway modulator. Bridging recent discoveries in fibrotic disease and stem cell biology, it delivers actionable guidance for researchers aiming to leverage pathway selectivity in preclinical models. Integrating recent evidence on SFRP1 and Wnt signaling, this thought-leadership piece positions HLY78 as a precision research tool—delving deeper than standard product pages by contextualizing its use in complex disease modeling and developmental biology.

• DAPI (hydrochloride): Technical Guidance for DNA Visualizati

  2026-08-05

  DAPI (hydrochloride) provides precise, high-contrast DNA labeling for chromosome staining, DNA quantitation, and cell cycle analysis, particularly in histochemical and cytometric workflows. It is best suited for researchers requiring reliable nuclear visualization in fixed or live cell systems, but low permeability in live cells and solubility constraints limit some applications. This article details actionable parameters and troubleshooting aligned with the product specification.

• hiPSC-Derived Intestinal Organoids Advance PK Modeling

  2026-08-05

  This study presents a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids (hiPSC-IOs), overcoming key limitations of traditional pharmacokinetic models. The resulting organoids exhibit robust self-renewal and differentiation, supporting more predictive in vitro drug metabolism and absorption studies.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page